|
業務類別
|
Diagnostics & Research |
|
業務概覽
|
GeneDx Holdings Corp focuses on genomics, creating the foundation for providing genomic information at scale and pioneering exome and genome sequencing for rare and ultra-rare genetic pediatric disorders. The company believes exome and genome testing will become the standard for diagnosing genetic disease, with the potential to transform healthcare from reactive to proactive. It aims to advance precision medicine by offering genetic diagnoses at the earliest moments, drivingimproved outcomes, and fueling discovery with genomic intelligence. Its operating segment mainly provides pediatric and rare disease diagnostics, focusing on whole exome and genome sequencing and, to a lesser extent, data and information services. |
| 公司地址
| 333 Ludlow Street, North Tower, 6th Floor, Stamford, CT, USA, 06902 |
| 電話號碼
| +1 888 729-1206 |
| 傳真號碼
| +1 201 421-2010 |
| 公司網頁
| https://www.genedx.com |
| 員工數量
| 1300 |
| Ms. Katherine A. Stueland |
Chief Executive Officer and Director |
美元 715.87K |
30/04/2026 |
| Mr. Kevin Feeley |
Chief Financial Officer |
美元 500.60K |
30/04/2026 |
| Mr. Mark A. Gardner |
President |
-- |
16/06/2026 |
| Dr. Bryan Dechairo, PhD |
Chief Operating Officer |
美元 436.15K |
30/04/2026 |
|
|
| Mr. Joshua Ruch |
Independent Director |
30/04/2026 |
| Mr. Keith A. Meister |
Independent Director |
30/04/2026 |
| Mr. Richard C. Pfenniger, Jr |
Independent Director |
30/04/2026 |
| Ms. Katherine A. Stueland |
Chief Executive Officer and Director |
30/04/2026 |
| Mr. Eli D. Casdin, M.B.A. |
Independent Director |
30/04/2026 |
| Dr. Emily M. Leproust, PhD |
Independent Director |
30/04/2026 |
| Dr. Thomas Fuchs, PhD |
Independent Director |
30/04/2026 |
|
|
|
|
